| 1 |
29433086 | Potential roles for glucagon-like peptide-17-36 amide and cholecystokinin in anorectic response to the trichothecene mycotoxin T-2 toxin. | 2018 May 30 |
2 |
| 2 |
24385417 | Role of cholecystokinin in anorexia induction following oral exposure to the 8-ketotrichothecenes deoxynivalenol, 15-acetyldeoxynivalenol, 3-acetyldeoxynivalenol, fusarenon X, and nivalenol. | 2014 Apr |
1 |
| 3 |
16998832 | Enhanced expression of cholecystokinin-2 receptor promotes the progression of colon cancer through activation of focal adhesion kinase. | 2006 Dec 15 |
1 |
| 4 |
15655524 | Gastrin promotes human colon cancer cell growth via CCK-2 receptor-mediated cyclooxygenase-2 induction and prostaglandin E2 production. | 2005 Feb |
1 |
| 5 |
10636070 | The effect of bombesin, cholecystokinin, gastrin, and their antagonists on proliferation of pancreatic cancer cell lines. | 1999 Dec |
1 |
| 6 |
9296353 | YM022 [(R)-1-[2,3-dihydro-1-(2'-methylphenacyl)-2-oxo-5-phenyl-1H-1,4- benzodiazepin-3-yl]-3-(3-methylphenyl)urea]: an irreversible cholecystokinin type-B receptor antagonist. | 1997 Jul 1 |
1 |
| 7 |
8928909 | Gastrin regulates growth of human pancreatic cancer in a tonic and autocrine fashion. | 1996 May |
1 |
| 8 |
7786960 | A placebo-controlled trial of L-365,260, a CCKB antagonist, in panic disorder. | 1995 Apr 1 |
2 |
| 9 |
8192551 | The panicogenic effects of cholecystokinin-tetrapeptide are antagonized by L-365,260, a central cholecystokinin receptor antagonist, in patients with panic disorder. | 1994 Jun |
1 |
| 10 |
10467593 | CCK-A and CCK-B receptors enhance olfactory recognition via distinct neuronal pathways. | 1994 Sep-Oct |
1 |
| 11 |
8222496 | The gastrin-receptor antagonist L-365,260 inhibits stimulated acid secretion in humans. | 1993 Nov |
1 |
| 12 |
8335062 | Cholecystokinin increases intracellular Ca2+ concentration in the Human JURKAT T Lymphocyte cell line. | 1993 May 15 |
1 |
| 13 |
1728842 | CCK antagonists and CCK-monoamine interactions in the control of satiety. | 1992 Jan |
1 |